The questions posed by Dr Ken Markel [BCMJ 2018;60:345 [11]] are shared by many of us, including me. The answers provided by Dr Brian Brodie [BCMJ 2018;60;345-346 [12]] do not address my concerns, which are:

1. What were the concerns that prompted the need to look for a buyer? The response from Dr Brodie that, “At the end of the day, it would have been very difficult for MD to remain relevant and stay competitive,” is vague and explains nothing. What was the crisis we were facing and why were we in that dire situation? What alternatives had been considered and dismissed? And by whom? Was this a unanimous decision?
2. Where is the money now (all of it)? Who was paid to arrange the sale and how much? How many buyers were considered?

—Jose Zanbilowicz, MDCM, FRCPC
Comox

This letter was submitted in response to “Sale of MD Financial Management” [11] and “Re: Sale of MD Financial Management; CMA Board Chair replies. [12]” [12]